Paul Lloyd

University of Cambridge

Papers

1

Total Citations

35

H-Index

1

About

Paul Lloyd is a leading urologic oncologist whose research centers on the surgical management of testicular cancer, with a particular focus on optimizing peri-operative outcomes through robotic-assisted techniques. His most-cited work, a comparative study of 100 consecutive post-chemotherapy and primary robot-assisted versus open retroperitoneal lymph node dissections (2021, 35 citations), has been instrumental in demonstrating the safety and feasibility of minimally invasive approaches in this complex patient population. Lloyd’s contributions have helped refine surgical protocols, reducing recovery times and complications while maintaining oncologic efficacy. His research bridges the gap between traditional open surgery and modern robotics, offering critical insights for surgeons managing high-risk testicular cancer cases. Beyond this landmark paper, Lloyd’s broader body of work continues to shape best practices in urologic oncology, earning him recognition as a key figure in advancing surgical innovation for young men facing this disease.

Research Focus

Key Achievements

1
H-Index
1
Papers
35
Total Citations
35
Avg Citations/Paper
🏆 Most Cited Paper
A comparative study of peri-operative outcomes for 100 consecutive post-chemotherapy and primary robot-assisted and open retroperitoneal lymph node dissections
35 citations · 2021
📈 Most Prolific Year: 2021 (1 Papers)
🤝 Key Collaborators: 18
🏛 Institutions: University of Cambridge

Top Papers

  1. 1

Key Collaborators

Contact & Links

Available for collaboration
Content generated · 12 days ago